FDA inspection
Novartis Grimsby Limited: FDA inspection ending Jun 9, 2017
FDA inspection 1017835 · Voluntary Action Indicated (VAI) · Grimsby
Key facts
| Inspection ID | 1017835 |
|---|---|
| Firm | Novartis Grimsby Limited |
| FEI number | 10656 |
| Address | Ne Lincolnshire, Moody Lane; Pyewipe |
| City | Grimsby |
| Country | United Kingdom |
| Fiscal year | 2017 |
| Inspection end date | Jun 9, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data